Denmark· DK-28106894823
Lurasidone "Orifarm"
A lurasidone product containing lurasidonhydrochlorid, registered in Denmark by Orifarm Healthcare A/S. The same ATC class is registered in 16 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Lurasidone is registered in 16 of 19 countries.
Countries holding a registration under ATC N05AE05 (lurasidone), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Lurasidone · ATC N05AE05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of lurasidone costs, country by country.
Normalised to the WHO defined daily dose (60 mg), the median price runs from $2.63 in Italy to $6.45 in Switzerland — a ×2.4 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lurasidone · price per daily dose (60 mg)
USD · FX 28 Sept 2026
- CH Switzerland$6.45
- IT Italy$2.63
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Lurasidonhydrochlorid
- Manufacturer
- Orifarm Healthcare A/S
- Country
- Denmark (DK)
- ATC code
- N05AE05
- ATC class
- Lurasidone
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106894823
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
242 interactions on record for lurasidone.
Graded by severity as the source publishes them — 32 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lurasidone · interactions on record
242 records
- 32 severe
- 205 moderate
Most severe, free to view
- MetoclopramideA03FA01severe
- AprepitantA04AD12severe
- KetoconazoleH02CA03severe
- ErythromycinJ01FA01severe
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N05AE05
Lurasidone, as other registers publish it.
- PolandAlurazenTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- PolandAlurazenTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- PolandAlurazenTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- PolandAsilFarmak International Sp. z o.o.
- PolandAsilFarmak International Sp. z o.o.
- PolandAsilFarmak International Sp. z o.o.
- CanadaAURO-LURASIDONEAURO PHARMA INC
- CanadaAURO-LURASIDONEAURO PHARMA INC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/468f62bf-5c07-4807-83ae-f065e1ea4c28 GET /v1/drugs/468f62bf-5c07-4807-83ae-f065e1ea4c28?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "18,5 mg",
"auth_role": "RMS",
"dk_drugid": "28106894823",
"substance": "Lurasidonhydrochlorid",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": true,
"registration_date_serial": "45547"
}See everything about lurasidone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.